H.Res. 1285 — Reported in House

IV House Calendar No. 127 117th CONGRESS 2d Session H. RES. 1285 [Report No. 117–520] IN THE HOUSE OF REPRESENTATIVES July 26, 2022Mr. Smith of Nebraska (for himself and Mr. Brady) submitted the following resolution; which was referred to the Committee on Ways and Means September 28, 2022Reported adversely from the Committee on Ways and Means, referred to the House Calendar, and ordered to be printed RESOLUTION Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights. That the President is requested to transmit to the House of Representatives, not later than 14 days after the date of the adoption of this resolution, copies of all documents, memoranda, advisory legal opinions, notes from meetings, audio recordings, records (including telephone and electronic mail records), correspondence, or other communications, or any portion of any such communications, to the extent that any such one or more items are within the possession of the President, that demonstrate— (1) the waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (in this resolution referred to as TRIPS waiver) that was agreed to on June 17, 2022, will increase global supply and delivery of COVID–19 vaccines; (2) the extent to which COVID–19 vaccines have been destroyed due to their expiration and the period during which this occurred; (3) the proposed expansion of the TRIPS waiver to cover intellectual property related to diagnostics and therapeutics (in this resolution referred to as the proposed TRIPS waiver expansion) will increase global supply and delivery of COVID–19 diagnostics or therapeutics; (4) the TRIPS waiver or the proposed TRIPS waiver expansion will accelerate the end of the COVID–19 pandemic; and (5) the People’s Republic of China will not obtain access to patents or other intellectual property related to COVID–19 vaccines, diagnostics, or therapeutics, even if China is expressly excluded from the TRIPS waiver or the proposed TRIPS waiver expansion. September 28, 2022Reported adversely from the Committee on Ways and Means, referred to the House Calendar, and ordered to be printed